MedTrace Logo

Active Surveillance for Low-risk Papillary Thyroid Carcinoma

NCT06261190 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 499

Last updated 2025-05-11

No results posted yet for this study

Summary

This is a multi-center, non-randomized, prospective observational cohort study aimed at establishing a cohort of low-risk papillary thyroid cancer patients with a maximum tumor diameter of 1.5 cm or less, consisting of an active surveillance group and an immediate surgery group.

Conditions

Sponsors & Collaborators

  • Seoul National University Bundang Hospital

    collaborator OTHER

  • SMG-SNU Boramae Medical Center

    collaborator OTHER

  • Seoul National University Hospital

    collaborator OTHER

  • National Cancer Center, Korea

    lead OTHER_GOV

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-06
Primary Completion
2029-12-31
Completion
2032-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06261190 on ClinicalTrials.gov